MX9604252A - Polipeptidos para diagnosticar infeccion con trypanosoma cruzi. - Google Patents

Polipeptidos para diagnosticar infeccion con trypanosoma cruzi.

Info

Publication number
MX9604252A
MX9604252A MX9604252A MX9604252A MX9604252A MX 9604252 A MX9604252 A MX 9604252A MX 9604252 A MX9604252 A MX 9604252A MX 9604252 A MX9604252 A MX 9604252A MX 9604252 A MX9604252 A MX 9604252A
Authority
MX
Mexico
Prior art keywords
polypeptides
terminal
region
tcr27
protein
Prior art date
Application number
MX9604252A
Other languages
English (en)
Other versions
MXPA96004252A (es
Inventor
Louis V Kirchhoff
Keiko Otsu
Original Assignee
Louis V Kirchhoff
Keiko Otsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22808904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9604252(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Louis V Kirchhoff, Keiko Otsu filed Critical Louis V Kirchhoff
Publication of MX9604252A publication Critical patent/MX9604252A/es
Publication of MXPA96004252A publication Critical patent/MXPA96004252A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen polipéptidos que son utiles para diagnosticar Tripanosomiasis Americana, o enfermedad de Chagas, una enfermedad causada por el agente infeccioso Trypanosoma cruzi. Los polipéptidos tienen una secuencia que corresponde a la secuencia de aminoácidos de cuando menos una de las regiones no repetitivas C-terminal y N-terminal de la proteína TCR27. El polipéptido puede comprender adicionalmente una secuencia de aminoácidos de una o más repeticiones a partir de la region central de la proteína TCR27. En una modalidad preferida, el polipéptido corresponde a la region no repetitiva N-terminal de la proteína TCR27, y cuando menos una repeticion a partir de la region central de la proteína TCR27, y no corresponde a la region no repetitiva C-terminal. Los polipéptidos pueden comprender además una secuencia enlazadora, ya sea en el término N o en el término C, para facilitar la union o la conjugacion con una molécula portadora en un sistema de soporte líquido o solido, para utilizarse en un ensayo sensible para detectar la infeccion por T. cruzi.
MXPA/A/1996/004252A 1994-03-24 1995-03-20 Polipeptidos para diagnosticar infeccion contrypanosoma cruzi MXPA96004252A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08216894 1994-03-24
US08/216,894 US5876734A (en) 1994-03-24 1994-03-24 Polypeptides for diagnosing infection with Trypanosoma cruzi
PCT/US1995/003191 WO1995025797A1 (en) 1994-03-24 1995-03-20 POLYPEPTIDES FOR DIAGNOSING INFECTION WITH $i(TRYPANOSOMA CRUZI)

Publications (2)

Publication Number Publication Date
MX9604252A true MX9604252A (es) 1998-05-31
MXPA96004252A MXPA96004252A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
AU1998295A (en) 1995-10-09
US6228601B1 (en) 2001-05-08
BR9507182B1 (pt) 2010-08-10
CA2186235A1 (en) 1995-09-28
US5876734A (en) 1999-03-02
WO1995025797A1 (en) 1995-09-28
BR9507182B8 (pt) 2014-10-14
BR9507182A (pt) 1997-10-14

Similar Documents

Publication Publication Date Title
WO2002010195A3 (en) Modified peptides with increased potency
EA200201121A1 (ru) Модуляторы рецепторов паратироидного гормона и родственного паратироидному гормону белка
LU91015I2 (fr) Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base
ES2229045T3 (es) Derivados de peptidos terapeuticos.
ATE428785T1 (de) Aktive und inactive cc-chemokinrezeptoren und nukleinsäuremoleküle, die für diesen rezeptor kodieren
ATE168415T1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
DE69838143D1 (de) Antimikrobielle peptide
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DE69033453D1 (de) Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose
Benditt et al. Interaction of a nuclear location signal with isolated nuclear envelopes and identification of signal-binding proteins by photoaffinity labeling.
CA2344590A1 (en) Treatment of inflammatory disease
EP1428835A4 (en) ANTIBODY AND ITS USE
MX9604252A (es) Polipeptidos para diagnosticar infeccion con trypanosoma cruzi.
CA2139518A1 (en) Antigenic regions of tlp complexes and antibodies against the same
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
DE69734893D1 (de) Rekombinante fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein (prrsv) und deren verwendung in der diagnose
ATE350398T1 (de) Protein s polypeptide und deren verwendungen
WO1992016623A3 (en) Receptors for bombesin-like peptides
DE69027542D1 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
HK1039946A1 (zh) 來源於sart-1的hla-a2限制性腫瘤抗原肽
DE69326145D1 (de) Synthetische peptide für die behandlung von myasthenia gravis
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
DE3886032D1 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
Kellaris Assessment of the number of free cysteines and isolation and identification of cystine-containing peptides from nicotinic acetylcholine receptor.